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lacing Faith in Numbers:
uantification of
erfusion With Myocardial
ontrast Echocardiography*
onathan R. Lindner, MD, FACC,
iri Sklenar, PHD
harlottesville, Virginia
linical decisions in cardiology are increasingly being based
n absolute measurements of chamber size, left ventricular
LV) performance and valve area. Accordingly, quantifica-
ion has become an integral part of echocardiography. A
elatively new application for echocardiography is the as-
essment of myocardial perfusion with myocardial contrast
chocardiography (MCE). This technique relies on the
coustic detection of microbubble contrast agents as they
ransit the microcirculation within the ultrasound beam.
etection of coronary stenosis and myocardial viability with
CE in patients has relied largely on subjective interpre-
ation of regional perfusion by experienced readers
See pages 1799 and 1807
ather than using quantitative techniques. Similar to radio-
uclide perfusion imaging, where interpretation has been
acilitated by quantification of single photon emission com-
uted tomography (SPECT) information (1,2), quantifica-
ion of MCE data will likely be necessary for its routine
pplication. The evaluation of perfusion with MCE relies
n measuring the product of microvascular blood volume
nd microvascular blood velocity (3). In this issue of the
ournal, two separate groups describe their experience with
elatively new methods for quantifying or displaying these
arameters (4,5). A critical analysis of the merits and
imitations of these studies sheds light on our expectations
rom computerized quantification and how we can avoid
sing “numerical information as a drunken man uses lam-
ost . . . for support rather than illumination” (Andrew
ang, 1844–1912).
OALS OF QUANTIFICATION
he primary reason for the routine use of quantification in
ardiac imaging is that it improves reproducibility and,
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Cardiovascular Imaging Center, Cardiovascular Division, University of
irginia School of Medicine, Charlottesville, Virginia. Dr. Lindner is supported by
rants from the National Institutes of Health (DK063508), Bethesda, Maryland, andflhe American Heart Association Mid-Atlantic Affiliate, Baltimore, Maryland.ometimes accuracy, of interpretation. For myocardial per-
usion imaging, quantification can have a positive effect on
any of the variables that influence interpretation, such as
eader expertise, reader bias, and imaging artifacts. Irrespec-
ive of the non-invasive imaging technique used, there is
nterobserver variability that can be explained by different
evels of experience or expertise. Disagreement in interpre-
ation can occur even between experienced readers and is
ften due to how imaging artifacts are handled. For lack of
etter terms, the interpreter must assume a certain position
n a receiver-operator curve. For example, some readers
ave a relatively low threshold for calling an abnormality a
erfusion defect, in which case their sensitivity will be high
t some expense to specificity and positive predictive value
or “over-callers,” in less-flattering terms). Other readers
ay have a much higher threshold for calling an abnormal-
ty a true perfusion defect, in which case specificity and
ositive predictive value will be better, but sensitivity will be
ower (“under-callers”). Although there are no perfect read-
rs, quantification of non-invasive imaging information has
he potential to improve both accuracy and uniformity of
nterpretation of myocardial perfusion (1,6). For echocardi-
graphy, quantification protocols based on border detection
r myocardial shortening velocities have been developed and
ested that can improve accuracy and uniformity in evalu-
ting systolic function (7,8).
One of the criteria by which we identify a reader as an
expert” in myocardial perfusion imaging is his or her ability
o distinguish artifacts from actual perfusion defects. Quan-
ification can reduce the influence of artifacts by several
eans. First, computerized quantification can be used to
stablish a database to be used as a normal standard to
orrect for commonly encountered artifacts. For example,
adionuclide imaging quantification programs have been
eveloped that use statistical variation of regional scinti-
raphic intensity based on body habitus and gender to help
he reader identify attenuation artifacts (1). Methods have
lso been developed for radionuclide imaging whereby
omputer analysis can numerically correct for signal atten-
ation caused by tissue and for depth-dependent scatter (9).
Beside enhancing diagnostic accuracy, a secondary role of
uantification in non-invasive imaging is to measure a
eaningful parameter that influences clinical decisions. For
xample, quantitative measurements of radionuclide tracer
ptake or positron emission tomography metabolic tracers
ave been used to indicate the degree of myocardial viabil-
ty. Thresholds have been established whereby the segmen-
al or global recovery of systolic function can be predicted
10). For the assessment of myocardial perfusion, absolute
uantification in terms of flow per muscle mass remains an
nmet goal and would improve detection of multivessel
isease, quantification of stenosis severity (by measuring
ow reserve), and assessment of viability.
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erfusion imaging with MCE is unique in both the infor-
ation it yields and the method by which this information
s acquired. Myocardial contrast echocardiography is per-
ormed with intravenous administration of encapsulated
icrobubble contrast agents. These microbubbles remain
ithin the vascular compartment and behave similar to red
lood cells in the microcirculation, where they are imaged
11). At a time when the microbubble concentration in the
lood pool is relatively constant, microbubbles within the
coustic beam are destroyed by high-power ultrasound. The
ate and extent of microbubble replenishment within the
eam, measured by acoustic enhancement, provide informa-
ion on microvascular blood velocity and blood volume,
espectively (3).
To date, most studies using MCE to assess regional
erfusion or viability have relied on subjective interpretation
f MCE images, which has several limitations. The first is
he inherent difficulty in visually identifying regional differ-
nces in the velocity parameter from movie clips or a series
f frames. Second, there are many imaging artifacts that can
roduce regional heterogeneity in contrast enhancement: for
xample, attenuation from microbubbles in the LV cavity,
here their concentration is 10- to 20-fold higher than in
he myocardium. Finally, despite recent advances in phased-
rray transducer technology, there is still substantial heter-
geneity of power in the acoustic field. This produces
eterogeneity in contrast-enhancement, depending on the
ocation of microbubbles in the acoustic beam and on the
osition of the acoustic focus. Attenuation and power
eterogeneity affect primarily the blood volume parameter
n MCE imaging. Although quantification is potentially
seful in avoiding these problems, absolute quantification of
CE data has been performed in few clinical studies
12,13).
DVANCES OF THE RECENT STUDIES
n the study by Yano et al. (4) in this issue of the Journal, the
uthors investigated the merits of a method for quantifying
icrovascular blood volume on MCE. They derived an
ndex of microvascular blood volume fraction in the myo-
ardium by comparing myocardial signal intensity to that in
he blood pool immediately adjacent in the LV cavity.
ecause acoustic intensity was measured in log-compressed
alues, the blood volume fraction (in relative units of dB)
as calculated by subtracting myocardial intensity from LV
avity intensity. This algorithm was designed to correct for
ar-field signal attenuation caused by tissue and to normalize
or heterogeneity in the acoustic power. As a result, spatial
eterogeneity from poor signal in the basal and lateral
egments was reduced, but not eliminated, in normal
ubjects. Using this technique, the authors also were able to
orrect for temporal heterogeneity in signal intensity caused
y a gradual decline in microbubble concentration that
ccurs after a bolus injection. oThe incremental diagnostic value of quantifying micro-
ascular blood volume is implied but not tested in the study
y Yano et al. (4). By correcting for attenuation, power
eterogeneity, and temporal variation in microbubble con-
entration, it should be possible to differentiate perfusion
efects from artifacts and to more accurately assess regional
erfusion. To determine whether the measurement of blood
olume fraction provides a meaningful measure of viability,
he investigators measured myocardial blood volume index
n patients with previous infarction. Their index of blood
olume fraction was accurate for identifying segments where
all motion would recover. Analysis of uncorrected data was
ess predictive. These results should be interpreted with
aution because only endocardial blood volume fraction was
uantified. Resting wall motion is largely dependent upon
he status of the endocardium (14). It cannot be inferred
hat this technique is a suitable indicator of transmural
iability for prediction of long-term outcomes, symptoms,
nd susceptibility to adverse remodeling. Other MCE
tudies have demonstrated that substantial viability often is
resent in segments that are akinetic at rest but possess
ontractile reserve (15,16). Further experience with this
trategy is needed to determine whether transmural correc-
ion is possible.
The study by Yu et al. (5), also in this issue of the Journal,
xamines the use of commercially produced software that
isplays the parameters of microvascular blood volume and
elocity and their product in color-coded formats. Paramet-
ic imaging for MCE was first described by our laboratory
ve years ago in a study designed to test whether transmural
ifferences in perfusion could be better represented (17).
he impact of the current study is substantially limited
ecause parametric imaging does not, per se, provide any
dditional quantitative information on perfusion. Instead, it
s a means of display and relies on subjective analysis of
atterns. Parametric imaging in its current form does not, as
uggested, reduce the “tedious” tasks of quantification,
ecause it still requires image selection, alignment, and
dentification of borders.
Parametric display has been particularly helpful for spa-
ially characterizing abnormalities in microvascular velocity
nd blood volume that occur in association with tumor
ngiogenesis (18). For myocardial perfusion imaging, this
echnique could similarly be helpful in spatially measuring
ow abnormalities and identifying attenuation artifacts that
ffect primarily microvascular blood volume but not blood
elocity values. It also has the advantage of providing a
ingle image for evaluating the microvascular blood velocity
arameter. For detecting the presence of perfusion defects,
e would expect a small impact from parametric imaging,
uch as the visual identification of mild or subendocardial
erfusion defects. It is, therefore, not surprising that Yu et
l. (5) found only a very modest increase in the correlation
etween MCE and radionuclide SPECT imaging with
arametric display. Moreover, the investigators did not use
ptimal qualitative methods to assess perfusion visually. Full
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Editorial Comment May 19, 2004:1814–6ideo clips rather than end-systolic data were viewed, which
an affect relative interpretation of the velocity parameter
19). Digital capture and side-by-side comparisons of rest
nd stress images are standard for both stress echocardiog-
aphy and radionuclide perfusion imaging, and they should
e considered standard for MCE. It is also important to
ote that because SPECT-sestamibi reflects microvascular
lood volume (20), only parametric blood volume maps
hould be used for comparison. The study also points out
ome of the limitations of parametric imaging. Fewer
egments could be assessed with parametric display than
tandard gray scale format, and from the illustrative images,
asal artifacts are still an obstacle.
UMMARY
t least for the near term, the assessment of myocardial
erfusion with non-invasive imaging will be the domain of
he clinician and not the computer. The development of
utomated or semi-automated computerized quantification
rograms has been driven by the need to enhance the
erformance of the human interpreter. To this end, the
elative impact of new technologies for quantification must
e evaluated in terms of whether a technology can improve
iagnostic accuracy, standardize interpretation, and derive
umerical values that have some clinical consequence.
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